ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,0765
0,33%
Bitcoin
63.006,86
6,57%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Blueprint Medicines Corporation (BPMC)

  7. Blueprint Medicines Corporation (BPMC) News

BPMC Blueprint Medicines Corporation

107,19
0,19 (0,18%)
Nach Börsenschluss
Zuletzt aktualisiert: 22:04:57
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Blueprint Medicines Corporation BPMC NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,19 0,18% 107,19 22:04:57
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
109,82 106,07 110,93 107,19 107,00
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
02.5.202413:00PRNUSBlueprint Medicines Reports Strong First Quarter 2024..
18.4.202414:00PRNUSBlueprint Medicines to Report First Quarter 2024 Financial..
11.4.202414:00PRNUSBlueprint Medicines to Host Webcast and Conference Call..
04.4.202422:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
11.3.202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.3.202423:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.3.202423:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.3.202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.3.202423:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.3.202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.3.202423:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.3.202423:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.3.202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202422:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
06.3.202416:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202400:19EDGAR2Form 144 - Report of proposed sale of securities
01.3.202421:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.2.202422:03EDGAR2Form 144 - Report of proposed sale of securities
23.2.202414:00PRNUSBlueprint Medicines Highlights AYVAKIT® (avapritinib)..
22.2.202414:20EDGAR2Form 8-K - Current report
16.2.202422:40EDGAR2Form S-8 - Securities to be offered to employees in employee..
15.2.202423:26EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15.2.202413:05EDGAR2Form 8-K - Current report
15.2.202413:00PRNUSBlueprint Medicines Reports Fourth Quarter and Full Year..
15.2.202400:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.2.202422:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
01.2.202414:00PRNUSBlueprint Medicines to Report Fourth Quarter and Full Year..
30.1.202400:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202422:13EDGAR2Form 144 - Report of proposed sale of securities
08.1.202414:03EDGAR2Form 8-K - Current report
08.1.202414:00PRNUSBlueprint Medicines Highlights 2024 Corporate Strategy and..
05.1.202422:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
26.12.202322:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.12.202322:09EDGAR2Form 144 - Report of proposed sale of securities
19.12.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.12.202314:00PRNUSBlueprint Medicines to Present at 42nd Annual J.P. Morgan..
15.12.202322:23EDGAR2Form 144 - Report of proposed sale of securities
13.12.202321:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.12.202314:05PRNUSBlueprint Medicines' AYVAKYT® (avapritinib) Receives..
11.12.202323:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.12.202318:30PRNUSBlueprint Medicines' Leadership in Driving Continued..
08.12.202300:09EDGAR2Form 144 - Report of proposed sale of securities

Kürzlich von Ihnen besucht

NASDAQ
BPMC
Blueprint Medicines
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten